BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11223746)

  • 1. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site.
    Gregori A; Vieweg J; Dahm P; Paulson DF
    Urol Int; 2001; 66(2):66-71. PubMed ID: 11223746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C; Louis P; Civantos F; Soloway MS
    J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
    Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
    J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping.
    Salomon L; Colombel M; Patard JJ; Lefrère-Belda MA; Bellot J; Chopin D; Abbou CC
    Eur Urol; 1999 Apr; 35(4):289-93. PubMed ID: 10087390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of transrectal ultrasound and sextant systematic core biopsy for performing radical prostatectomy].
    Fujimoto H; Tobisu K; Niwakawa M; Kume H; Tomita K; Mizutani T; Tsutsumi M; Kakizoe T
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):479-87. PubMed ID: 9155115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of sextant biopsies to predict radical prostatectomy stage.
    Wills ML; Sauvageot J; Partin AW; Gurganus R; Epstein JI
    Urology; 1998 May; 51(5):759-64. PubMed ID: 9610589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.
    Graefen M; Haese A; Pichlmeier U; Hammerer PG; Noldus J; Butz K; Erbersdobler A; Henke RP; Michl U; Fernandez S; Huland H
    J Urol; 2001 Mar; 165(3):857-63. PubMed ID: 11176486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.
    Peller PA; Young DC; Marmaduke DP; Marsh WL; Badalament RA
    Cancer; 1995 Jan; 75(2):530-8. PubMed ID: 7529129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens.
    Altay B; Kefi A; Nazli O; Killi R; Semerci B; Akar I
    Urol Int; 2001; 67(1):14-8. PubMed ID: 11464109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
    Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
    Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
    Epstein JI; Walsh PC; Sauvageot J; Carter HB
    J Urol; 1997 Nov; 158(5):1886-90. PubMed ID: 9334623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database.
    Turley RS; Hamilton RJ; Terris MK; Kane CJ; Aronson WJ; Presti JC; Amling CL; Freedland SJ;
    J Urol; 2008 Feb; 179(2):523-7; discussion 527-8. PubMed ID: 18076952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.
    Carter HB; Sauvageot J; Walsh PC; Epstein JI
    J Urol; 1997 Jun; 157(6):2206-9. PubMed ID: 9146616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of three additional mid biopsies to improve local assessment of prostate cancer in patients with one positive sextant biopsy.
    Salomon L; Colombel M; Patard JJ; Bellot J; Chopin DK; Abbou CC
    Eur Urol; 1998 Oct; 34(4):313-7. PubMed ID: 9748678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.
    Elliott SP; Shinohara K; Logan SL; Carroll PR
    J Urol; 2002 Jul; 168(1):105-9. PubMed ID: 12050501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.